Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

β-Adrenergics enhance brain extraction of levodopa

Identifieur interne : 006595 ( Main/Merge ); précédent : 006594; suivant : 006596

β-Adrenergics enhance brain extraction of levodopa

Auteurs : Ergun Y. Uc [États-Unis] ; Gerald A. Dienel [États-Unis] ; Nancy F. Cruz [États-Unis] ; Sami I. Harik [États-Unis]

Source :

RBID : Pascal:02-0204552

Descripteurs français

English descriptors

Abstract

We sought to determine whether (3-adrenergic agonists enhance the brain extraction of L-dopa and L-leucine, Systemic administration of β-adrenergic agonists increase brain concentrations of L-dopa and other large neutral amino acids (LNAA) in rats and monkeys and may improve symptoms and reduce daily L-dopa requirement in patients with Parkinson's disease. Cerebral blood flow (CBF) using [3H]nicotine and the extraction fraction of 14C-labeled L-dopa or L-leucine were measured simultaneously in various brain regions of conscious rats using the dual-isotope indicator fractionation technique after intraperitoneal administration of isoproterenol (a peripheral nonselective (3-adrenergic agonist), or clenbuterol (a β2-adrenergic agonist that crosses the blood-brain barrier), or β-adrenergic agonist preceded by nadolol (a peripheral nonselective β-adrenergic antagonist), or saline vehicle. Both β-adrenergic agonists increased regional brain extraction fraction of L-dopa and L-leucine tracers by 35-45%, without altering regional CBF. These changes were accompanied by about a 30% decrease in plasma branched chain LNAA concentrations. Nadolol blocked all these effects. (3-Adrenergic agonists increase the brain extraction of L-dopa and leucine, mainly by peripheral mechanisms that reduce the levels of other competing plasma LNAAs for transport. Thus, β-adrenergic agonists might be useful in the treatment of patients with Parkinson's disease by enhancing delivery of L-dopa to the brain.

Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:02-0204552

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">β-Adrenergics enhance brain extraction of levodopa</title>
<author>
<name sortKey="Uc, Ergun Y" sort="Uc, Ergun Y" uniqKey="Uc E" first="Ergun Y." last="Uc">Ergun Y. Uc</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Department of Neurology, University of Arkansas for Medical Sciences</s1>
<s2>Little Rock, Arkansas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Arkansas</region>
</placeName>
</affiliation>
<affiliation wicri:level="2">
<inist:fA14 i1="02">
<s1>Central Arkansas Veterans Healthcare System</s1>
<s2>Little Rock, Arkansas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Arkansas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Dienel, Gerald A" sort="Dienel, Gerald A" uniqKey="Dienel G" first="Gerald A." last="Dienel">Gerald A. Dienel</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Department of Neurology, University of Arkansas for Medical Sciences</s1>
<s2>Little Rock, Arkansas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Arkansas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Cruz, Nancy F" sort="Cruz, Nancy F" uniqKey="Cruz N" first="Nancy F." last="Cruz">Nancy F. Cruz</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Department of Neurology, University of Arkansas for Medical Sciences</s1>
<s2>Little Rock, Arkansas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Arkansas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Harik, Sami I" sort="Harik, Sami I" uniqKey="Harik S" first="Sami I." last="Harik">Sami I. Harik</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Department of Neurology, University of Arkansas for Medical Sciences</s1>
<s2>Little Rock, Arkansas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Arkansas</region>
</placeName>
</affiliation>
<affiliation wicri:level="2">
<inist:fA14 i1="02">
<s1>Central Arkansas Veterans Healthcare System</s1>
<s2>Little Rock, Arkansas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Arkansas</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">02-0204552</idno>
<date when="2002">2002</date>
<idno type="stanalyst">PASCAL 02-0204552 INIST</idno>
<idno type="RBID">Pascal:02-0204552</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002850</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000471</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002556</idno>
<idno type="wicri:doubleKey">0885-3185:2002:Uc E:adrenergics:enhance:brain</idno>
<idno type="wicri:Area/Main/Merge">006595</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">β-Adrenergics enhance brain extraction of levodopa</title>
<author>
<name sortKey="Uc, Ergun Y" sort="Uc, Ergun Y" uniqKey="Uc E" first="Ergun Y." last="Uc">Ergun Y. Uc</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Department of Neurology, University of Arkansas for Medical Sciences</s1>
<s2>Little Rock, Arkansas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Arkansas</region>
</placeName>
</affiliation>
<affiliation wicri:level="2">
<inist:fA14 i1="02">
<s1>Central Arkansas Veterans Healthcare System</s1>
<s2>Little Rock, Arkansas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Arkansas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Dienel, Gerald A" sort="Dienel, Gerald A" uniqKey="Dienel G" first="Gerald A." last="Dienel">Gerald A. Dienel</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Department of Neurology, University of Arkansas for Medical Sciences</s1>
<s2>Little Rock, Arkansas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Arkansas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Cruz, Nancy F" sort="Cruz, Nancy F" uniqKey="Cruz N" first="Nancy F." last="Cruz">Nancy F. Cruz</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Department of Neurology, University of Arkansas for Medical Sciences</s1>
<s2>Little Rock, Arkansas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Arkansas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Harik, Sami I" sort="Harik, Sami I" uniqKey="Harik S" first="Sami I." last="Harik">Sami I. Harik</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Department of Neurology, University of Arkansas for Medical Sciences</s1>
<s2>Little Rock, Arkansas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Arkansas</region>
</placeName>
</affiliation>
<affiliation wicri:level="2">
<inist:fA14 i1="02">
<s1>Central Arkansas Veterans Healthcare System</s1>
<s2>Little Rock, Arkansas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Arkansas</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2002">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Agonist</term>
<term>Animal</term>
<term>Antagonist</term>
<term>Antiparkinson agent</term>
<term>Biological effect</term>
<term>Brain (vertebrata)</term>
<term>Chemotherapy</term>
<term>Clenbuterol</term>
<term>Isoprenaline</term>
<term>Leucine</term>
<term>Levodopa</term>
<term>Mechanism of action</term>
<term>Nadolol</term>
<term>Rat</term>
<term>β-Adrenergic receptor agonist</term>
<term>β2-Adrenergic receptor</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Clenbutérol</term>
<term>Agoniste</term>
<term>Récepteur β2-adrénergique</term>
<term>Stimulant β-adrénergique</term>
<term>Chimiothérapie</term>
<term>Antiparkinsonien</term>
<term>Isoprénaline</term>
<term>Nadolol</term>
<term>Antagoniste</term>
<term>Lévodopa</term>
<term>Leucine</term>
<term>Encéphale</term>
<term>Effet biologique</term>
<term>Mécanisme action</term>
<term>Rat</term>
<term>Animal</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We sought to determine whether (3-adrenergic agonists enhance the brain extraction of L-dopa and L-leucine, Systemic administration of β-adrenergic agonists increase brain concentrations of L-dopa and other large neutral amino acids (LNAA) in rats and monkeys and may improve symptoms and reduce daily L-dopa requirement in patients with Parkinson's disease. Cerebral blood flow (CBF) using [
<sup>3</sup>
H]nicotine and the extraction fraction of
<sup>14</sup>
C-labeled L-dopa or L-leucine were measured simultaneously in various brain regions of conscious rats using the dual-isotope indicator fractionation technique after intraperitoneal administration of isoproterenol (a peripheral nonselective (3-adrenergic agonist), or clenbuterol (a β
<sub>2</sub>
-adrenergic agonist that crosses the blood-brain barrier), or β-adrenergic agonist preceded by nadolol (a peripheral nonselective β-adrenergic antagonist), or saline vehicle. Both β-adrenergic agonists increased regional brain extraction fraction of L-dopa and L-leucine tracers by 35-45%, without altering regional CBF. These changes were accompanied by about a 30% decrease in plasma branched chain LNAA concentrations. Nadolol blocked all these effects. (3-Adrenergic agonists increase the brain extraction of L-dopa and leucine, mainly by peripheral mechanisms that reduce the levels of other competing plasma LNAAs for transport. Thus, β-adrenergic agonists might be useful in the treatment of patients with Parkinson's disease by enhancing delivery of L-dopa to the brain.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Arkansas</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Arkansas">
<name sortKey="Uc, Ergun Y" sort="Uc, Ergun Y" uniqKey="Uc E" first="Ergun Y." last="Uc">Ergun Y. Uc</name>
</region>
<name sortKey="Cruz, Nancy F" sort="Cruz, Nancy F" uniqKey="Cruz N" first="Nancy F." last="Cruz">Nancy F. Cruz</name>
<name sortKey="Dienel, Gerald A" sort="Dienel, Gerald A" uniqKey="Dienel G" first="Gerald A." last="Dienel">Gerald A. Dienel</name>
<name sortKey="Harik, Sami I" sort="Harik, Sami I" uniqKey="Harik S" first="Sami I." last="Harik">Sami I. Harik</name>
<name sortKey="Harik, Sami I" sort="Harik, Sami I" uniqKey="Harik S" first="Sami I." last="Harik">Sami I. Harik</name>
<name sortKey="Uc, Ergun Y" sort="Uc, Ergun Y" uniqKey="Uc E" first="Ergun Y." last="Uc">Ergun Y. Uc</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006595 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 006595 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     Pascal:02-0204552
   |texte=   β-Adrenergics enhance brain extraction of levodopa
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024